Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)

NCT06887062 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT06887062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06887062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)
Lead sponsor
University of Edinburgh
Phase
Phase 2
Overall status
Recruiting
Start date
March 21, 2025
Completion date
July 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell arteritis (gca), large vessel vasculitis, takayasu arteritis